Healthcare Quality, Patient Safety & Policy

Fidelis Care Opens Maternal Health Grant Applications in NY

Grants aim to support innovative strategies in postpartum care and maternal mental health in underserved and vulnerable communities

Fidelis Care, a statewide health plan with more than 2.4 million members in New York State and a Centene Corporation company, has opened the application process for its 2025 maternal health grant program. The grants, open to healthcare providers and community-based organizations in New York, aim to fund programs that support innovative strategies in postpartum care and maternal mental health. The application is available at fideliscare.org/maternal-grant. The deadline to apply is 5 p.m. July 8, 2025.  

Postpartum care and maternal mental health are critical components of long-term health and well-being for new mothers and their families. The Substance Abuse and Mental Health Services Administration (SAMHSA) says mental health conditions, including depression and anxiety, are among the most common complications of pregnancy, affecting an estimated one in five individuals annually in the United States. Postpartum care attendance is inconsistent, with mean attendance rates in the U.S. around 72%, and even lower among the most vulnerable populations, such as those served by Federally Qualified Health Centers, where non-attendance can reach 43%. Access to health insurance has been associated with higher postpartum visit attendance, which is essential for screening and addressing both physical and mental health needs after childbirth. 

“As a healthcare community, we must recognize that supporting mothers after childbirth is just as vital as caring for them during pregnancy,” said Fidelis Care Chief Medical Officer Dr. Vincent Marchello. “Ensuring access to postpartum care and mental health services not only improves the well-being of mothers but also strengthens families and communities as a whole.”

Fidelis Care plans to announce the recipients of its 2025 maternal health grants in August. 

Related posts

Trial Shows Active Chest Tube Clearance Boosts Cardiac Outcomes

Business Wire

Asgard Therapeutics Adds Top Experts to Board, Boosting Drug & Cancer Immunotherapy

PR Newswire

6th Global Pharma Picks LifeSphere NavaX for GenAI Case Processing

PR Newswire